Kim TY - Search Results

1

Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial.

Sclafani F, Kim TY, Cunningham D, Kim TW, Tabernero J, Schmoll HJ, Roh JK, Kim SY, Park YS, Guren TK, Hawkes E, Clarke SJ, Ferry D, Frodin JE, Ayers M, Nebozhyn M, Peckitt C, Loboda A, Watkins DJ. Sclafani F, et al. Among authors: kim tw, kim ty, kim sy. Int J Cancer. 2017 Jan 15;140(2):431-439. doi: 10.1002/ijc.30453. Epub 2016 Oct 17. Int J Cancer. 2017. PMID: 27681944 Free article. Clinical Trial.

2

A phase III randomized trial of combined chemoradiotherapy versus radiotherapy alone in locally advanced non-small-cell lung cancer.

Kim TY, Yang SH, Lee SH, Park YS, Im YH, Kang WK, Ha SH, Park CI, Heo DS, Bang YJ, Kim NK. Kim TY, et al. Among authors: kim nk. Am J Clin Oncol. 2002 Jun;25(3):238-43. doi: 10.1097/00000421-200206000-00007. Am J Clin Oncol. 2002. PMID: 12040280 Clinical Trial.

3

Doxorubicin-based chemotherapy for diffuse large B-cell lymphoma in elderly patients: comparison of treatment outcomes between young and elderly patients and the significance of doxorubicin dosage.

Lee KW, Kim DY, Yun T, Kim DW, Kim TY, Yoon SS, Heo DS, Bang YJ, Park S, Kim BK, Kim NK. Lee KW, et al. Among authors: kim dw, kim dy, kim ty, kim bk, kim nk. Cancer. 2003 Dec 15;98(12):2651-6. doi: 10.1002/cncr.11846. Cancer. 2003. PMID: 14669285 Free article.

4

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa, ZD1839) in chemotherapy-resistant non-small cell lung cancer.

Han SW, Hwang PG, Chung DH, Kim DW, Im SA, Kim YT, Kim TY, Heo DS, Bang YJ, Kim NK. Han SW, et al. Among authors: kim dw, kim ty, kim yt, kim nk. Int J Cancer. 2005 Jan 1;113(1):109-15. doi: 10.1002/ijc.20550. Int J Cancer. 2005. PMID: 15386420 Free article. Clinical Trial.

5

Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.

Kim DW, Jo YH, Kim JH, Wu HG, Rhee CS, Lee CH, Kim TY, Heo DS, Bang YJ, Kim NK. Kim DW, et al. Among authors: kim ty, kim nk, kim jh. Cancer. 2004 Nov 15;101(10):2257-60. doi: 10.1002/cncr.20648. Cancer. 2004. PMID: 15484215 Free article.

6

A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma.

Sun JM, Han W, Im SA, Kim TY, Park IA, Noh DY, Heo DS, Bang YJ, Choe KJ, Kim NK. Sun JM, et al. Among authors: kim ty, kim nk. Cancer. 2004 Dec 1;101(11):2516-22. doi: 10.1002/cncr.20665. Cancer. 2004. PMID: 15517588 Free article.

7

Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer.

Kim JH, Oh DY, Kim YJ, Han SW, Choi IS, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK. Kim JH, et al. Among authors: kim yj, kim dw, kim ty, kim nk. J Korean Med Sci. 2005 Oct;20(5):806-10. doi: 10.3346/jkms.2005.20.5.806. J Korean Med Sci. 2005. PMID: 16224154 Free PMC article.

8

Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation.

Han SW, Kim TY, Jeon YK, Hwang PG, Im SA, Lee KH, Kim JH, Kim DW, Heo DS, Kim NK, Chung DH, Bang YJ. Han SW, et al. Among authors: kim dw, kim ty, kim nk, kim jh. Clin Cancer Res. 2006 Apr 15;12(8):2538-44. doi: 10.1158/1078-0432.CCR-05-2845. Clin Cancer Res. 2006. PMID: 16638863

9

High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy.

Lee KH, Lee SH, Kim DW, Kang WJ, Chung JK, Im SA, Kim TY, Kim YW, Bang YJ, Heo DS. Lee KH, et al. Among authors: kim dw, kim ty, kim yw. Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4232-6. doi: 10.1158/1078-0432.CCR-05-2710. Clin Cancer Res. 2006. PMID: 16857796

10

Phase II trial of gemcitabine combined with cisplatin in patients with inoperable biliary tract carcinomas.

Lee J, Kim TY, Lee MA, Ahn MJ, Kim HK, Lim HY, Lee NS, Park BJ, Kim JS; Korean Cancer Study Group. Lee J, et al. Among authors: kim hk, kim ty, kim js. Cancer Chemother Pharmacol. 2008 Jan;61(1):47-52. doi: 10.1007/s00280-007-0444-5. Epub 2007 Mar 16. Cancer Chemother Pharmacol. 2008. PMID: 17364190 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,569 results

Search Page